Kusaka Toshimasa, Nakayama Masafumi, Nakamura Kyohei, Ishimiya Mai, Furusawa Emi, Ogasawara Kouetsu
Department of Immunobiology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan.
Department of Immunobiology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan; Frontier Research Institute for Interdisciplinary Sciences, Tohoku University, Sendai, Japan.
PLoS One. 2014 Mar 28;9(3):e92634. doi: 10.1371/journal.pone.0092634. eCollection 2014.
Amorphous silica particles, such as nanoparticles (<100 nm diameter particles), are used in a wide variety of products, including pharmaceuticals, paints, cosmetics, and food. Nevertheless, the immunotoxicity of these particles and the relationship between silica particle size and pro-inflammatory activity are not fully understood. In this study, we addressed the relationship between the size of amorphous silica (particle dose, diameter, number, and surface area) and the inflammatory activity (macrophage phagocytosis, inflammasome activation, IL-1β secretion, cell death and lung inflammation). Irrespective of diameter size, silica particles were efficiently internalized by mouse bone marrow-derived macrophages via an actin cytoskeleton-dependent pathway, and induced caspase-1, but not caspase-11, activation. Of note, 30 nm-1000 nm diameter silica particles induced lysosomal destabilization, cell death, and IL-1β secretion at markedly higher levels than did 3000 nm-10000 nm silica particles. Consistent with in vitro results, intra-tracheal administration of 30 nm silica particles into mice caused more severe lung inflammation than that of 3000 nm silica particles, as assessed by measurement of pro-inflammatory cytokines and neutrophil infiltration in bronchoalveolar lavage fluid of mice, and by the micro-computed tomography analysis. Taken together, these results suggest that silica particle size impacts immune responses, with submicron amorphous silica particles inducing higher inflammatory responses than silica particles over 1000 nm in size, which is ascribed not only to their ability to induce caspase-1 activation but also to their cytotoxicity.
无定形二氧化硅颗粒,如纳米颗粒(直径<100nm的颗粒),被广泛应用于各种产品中,包括药品、涂料、化妆品和食品。然而,这些颗粒的免疫毒性以及二氧化硅颗粒大小与促炎活性之间的关系尚未完全明确。在本研究中,我们探讨了无定形二氧化硅的大小(颗粒剂量、直径、数量和表面积)与炎症活性(巨噬细胞吞噬作用、炎性小体激活、IL-1β分泌、细胞死亡和肺部炎症)之间的关系。无论直径大小,二氧化硅颗粒均可通过肌动蛋白细胞骨架依赖性途径被小鼠骨髓来源的巨噬细胞有效内化,并诱导caspase-1而非caspase-11激活。值得注意的是,直径为30nm - 1000nm的二氧化硅颗粒诱导溶酶体不稳定、细胞死亡和IL-1β分泌的水平明显高于直径为3000nm - 10000nm的二氧化硅颗粒。与体外实验结果一致,通过检测小鼠支气管肺泡灌洗液中的促炎细胞因子和中性粒细胞浸润以及微计算机断层扫描分析评估,向小鼠气管内注射30nm二氧化硅颗粒比注射3000nm二氧化硅颗粒引起更严重的肺部炎症。综上所述,这些结果表明二氧化硅颗粒大小会影响免疫反应,亚微米级无定形二氧化硅颗粒比尺寸超过1000nm的二氧化硅颗粒诱导更高的炎症反应,这不仅归因于它们诱导caspase-1激活的能力,还归因于它们的细胞毒性。